Wealthfront Advisers
CLOV icon

Wealthfront Advisers’s Clover Health Investments CLOV Stock Holding History

Wealthfront Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,023
Closed -$22.9K – 1122
2026
Q1 		$22.9K Buy
+13,023
New +$28.2K ﹤0.01% 1073
2025
Q4 		– Sell
-15,140
Closed -$46.3K – 1059
2025
Q3 		$46.3K Sell
15,140
-2,980
-16% -$8.51K ﹤0.01% 1002
2025
Q2 		$50.6K Buy
+18,120
New +$59.6K ﹤0.01% 958

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Wealthfront Advisers's CLOV Position: Q2 2026 in Review

Wealthfront Advisers sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 13,023 shares — an estimated $22.9K sold.

Wealthfront Advisers first reported a position in CLOV in Q2 2025 and held it in 3 quarters. The position peaked at $50.6K in Q2 2025. 131 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Wealthfront Advisers reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
  • Wealthfront Advisers sold 13,023 Clover Health Investments shares in Q2 2026, an estimated $22.9K.
  • Wealthfront Advisers first reported a position in Clover Health Investments in Q2 2025 and held it in 3 quarters.
  • Wealthfront Advisers's Clover Health Investments position peaked at $50.6K in Q2 2025.
  • 131 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.